Active, Not Recruiting A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis NCT06329401 Conditions Alveolitis, Extrinsic Allergic, Fibrosis, Hypersensitivity, +18 more Locations University of Alabama at Birmingham — Birmingham, Alabama, United States Mayo Clinic- Scottsdale — Scottsdale, Arizona, United States University of Southern California — Los Angeles, California, United States Cedars-Sinai — Los Angeles, California, United States View all 154 locations View more locations Show fewer locations Loading locations... View Trial Details
